It is not a good time for drugs, two batches of a cancer drug have been withdrawn, the same pharmacy has voluntarily recalled it as a precaution, we are talking about the medical specialty Mitomycin Medac.
Let's see what are the properties of the drug and all the selected batches
Let's see what are the characteristics of the product on the alert, the medical specialty is Mitomicina Medac from the Medac Pharma company in Rome, we see specifically which batches are affected:
1) lot number C0180101A expiring on 31-03-2020, 1 MG / ML powder for solution for injection or infusion, or for intravesical use AIC 044530107
2) lot number D180101A expiring on 31
Mitomycin is recommended for the treatment of certain types of neoplasia, the determination was necessary after communication by the same company Medac Pharma srl about an increase of Invisible Particles
It is recommended that gentlemen consumers be very careful when using this drug. If you have packages with the drug in readiness, all you need to do is make sure that you are not part of these prepared parties. If they instead match the reported lots, all you have to do is return what you bought it to, it will change to a drug that is not on the alert or request a full refund, it does not require a receipt.
Retired drug for carcinogenic pollution: here's brand and lots
Follow us on: Facebook – Twitter – Gnews – Telegram – Instragram – Pinterest – Youtube – contact us on WhatsApp at the new number 3516559380 – enter this number in the address book and send us the following message via WhatsApp: "news", we will respond as soon as possible.